Release Date: July 11, 2025
Expiration Date: July 11, 2026
Activity Overview
This educational activity is an archive of the live presentation held on May 30, 2025.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward physicians, nurses, NPs/PAs, and other HCPs involved in the treatment and management of colorectal cancer.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Define key biomarkers that guide personalized treatment decision-making in patients with metastatic colorectal cancer (mCRC), incorporating multidisciplinary team support
- Apply the latest data on current and emerging treatment options for mCRC, including targeted therapies (e.g., BRAF, HER2, KRAS), into clinical practice for optimal patient outcomes
- Identify strategies for monitoring and managing adverse effects of current and emerging therapies for mCRC to ensure treatment adherence and patient safety

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here